Phase II selection design trial of concurrent chemotherapy + cetuximab vs. chemotherapy then cetuximab in advanced non-small cell lung cancer (NSCLC).
Phase of Trial: Phase II
Latest Information Update: 14 Oct 2017
At a glance
- Drugs Cetuximab (Primary) ; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Biomarker; Pharmacogenomic; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 31 Oct 2012 Actual end date Jul 2011 added as reported by ClinicalTrials.gov.
- 10 Aug 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History